←
Portage Biotech233 posts
Portage Biotech avatar

Portage Biotech

@PortageBiotech

Portage Biotech is developing first-in-class immuno-oncology therapies to help more patients achieve durable treatment responses and a better quality of life.

◷ Joined March 2021▧ 200 Photos and videos
Portage Biotech avatar
Portage Biotech@PortageBiotech·16 Aug 2023

Listen to our CFO, Allan Shaw on this #BusinessOfBiotech episode, where he & host @mattpillar discuss cash management and "runway preservation" for new & emerging #biopharma companies, #financing during clinical trials, managing funds and more here: brnw.ch/21wBHzH $PRTG

Portage Biotech avatar
Portage Biotech@PortageBiotech·26 Jun 2023

We’re excited to announce that we have dosed the first patient in our Phase 1a trial evaluating our adenosine 2A receptor inhibitor in select solid tumors. We look forward to exploring our next-gen approach to target the #adenosine pathway. Learn more: fal.cn/3zoW9

Post attachment
Portage Biotech avatar
Portage Biotech@PortageBiotech·1 May 2023

Check out this episode of @molecule2markt podcast, featuring our CEO Ian Walters! Ian discusses his background in the industry, along with Portage’s business model and progress in the clinic. Learn more about what makes Portage unique here: https://t.co/a5828ZVeNJ

Post attachment
Portage Biotech avatar
Portage Biotech@PortageBiotech·28 Apr 2023

Our CFO, Allan Shaw, was recently a guest on @molecule2markt podcast, where he discusses his views on the state of the market and potential opportunities for companies to be capital-efficient. Listen here: https://t.co/sacH0qpbnE

Post attachment